A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4(+) CD25(+) FOXP3(+) Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)

Схожие документы

• Tolerogenic vaccines: targeting the antigenic and cytokine niches of FOXP3(+) regulatory T cells
  по: Mannie, Mark D., et al.
  Опубликовано: (2020)
• Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3+ Tregs in vitro
  по: Kayla B. DeOca, et al.
  Опубликовано: (2020-09-01)
• Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3(+) Tregs in vitro
  по: DeOca, Kayla B., et al.
  Опубликовано: (2020)
• A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4(+) CD25(high) FOXP3(+) Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition
  по: Moorman, Cody D., et al.
  Опубликовано: (2019)
• Interferon-β (IFN-β) facilitates neuroantigen-dependent induction of CD25(+) FOXP3(+) regulatory T cells that suppress experimental autoimmune encephalomyelitis (EAE)()
  по: Wang, Duncheng, et al.
  Опубликовано: (2016)